Quick Answer
Decoy Therapeutics Inc. reported Net Income Loss of -$12.52 million for the year ending 2025.
- Decoy Therapeutics Inc. showed a decrease of -124.5% in Net Income Loss from 2024 to 2025.
- This data is from Decoy Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), Decoy Therapeutics Inc.'s Net Income Loss has declined by 13,400.9%.
- Historical annual values: Fiscal year 2025: -$12.52 million | Fiscal year 2024: -$5.58 million | Fiscal year 2023: -$12.54 million | Fiscal year 2022: -$31.61 million | Fiscal year 2021: -$12.77 million | Fiscal year 2020: -$7.35 million | Fiscal year 2019: -$6.94 million | Fiscal year 2018: -$1.67 million | Fiscal year 2017: -$34.43 million | Fiscal year 2016: -$39.49 million | Fiscal year 2015: -$29.14 million | Fiscal year 2014: -$92.7 thousand.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: